Protocol changes—even those made because a drug is performing better than expected—can wreak havoc with study timelines and budgets. When one emerging biotech faced a protocol change that would render the Interactive Response Technology (IRT) system for Part II of the study unusable, Almac staff snapped into action with a creative, schedule-saving solution.